New hope from South Korea ... a giant company confirms the effectiveness of its treatment against Corona
The giant South Korean pharmaceutical industries company, "Celterion", said today, Wednesday, that its candidate treatment for the Coronavirus reduces the recovery period and reduces the chances of the disease developing into a serious condition.
According to the South Korean "Yonhap" agency;
The company earlier submitted an application for a conditional marketing permit for its treatment to the South Korean Ministry of Food and Drug Safety.
The company disclosed clinical data for its second phase treatment trials.
The company conducted its tests on 327 patients with the virus to evaluate the effectiveness and safety of the treatment.
Nearly 60% of the study participants had severe symptoms, including pneumonia.
The company said that the treatment reduced the rate of progression of patients to critical cases requiring hospital care by 54%.
Among patients aged 50 years and over, the rate of developing severe cases decreased by 68%.
The company added that the treatment reduced the recovery time by more than three days.
She explained that among patients aged 50 years and over, treatment reduced recovery time by more than five or six days.
The company stated that it plans to conduct a third phase of clinical trials, which is a pivotal part of the study, in more than 10 countries, to obtain more comprehensive results for the safety and effectiveness of the treatment.
The company also plans to apply for an emergency use permit to the US Food and Drug Administration, and for a conditional marketing license to the European Medicines Agency in the coming months.
The company is also working to increase its manufacturing capacity to meet global and local demand, which is expected to reach a maximum of two million doses.
It is reported that the treatment was injected intravenously for 90 minutes.
Follow our latest local and sports news, and the latest political and economic developments via Google news